Artigo Acesso aberto Revisado por pares

Dual Functions of Prostaglandin D2 in Murine Contact Hypersensitivity via DP and CRTH2

2011; Elsevier BV; Volume: 179; Issue: 1 Linguagem: Inglês

10.1016/j.ajpath.2011.03.047

ISSN

1525-2191

Autores

Yoshihiro Yamamoto, Shinobu Otani, Hiroyuki Hirai, Kinya Nagata, Kosuke Aritake, Yoshihiro Urade, Shuh Narumiya, Hiroo Yokozeki, Masataka Nakamura, Takahiro Satoh,

Tópico(s)

Vitamin D Research Studies

Resumo

Prostaglandin D2 (PGD2) exerts its effects through two distinct receptors: the chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) and the D prostanoid (DP) receptor. Our previous study demonstrated that CRTH2 mediates contact hypersensitivity (CHS) in mice. However, the function of DP receptor remains to be fully established. In this study, we examine the pathophysiological roles of PGD2 using DP-deficient (DP−/−) and CRTH2/DP-deficient (CRTH2−/−/DP−/−) mice to elucidate receptor-mediated PGD2 action in CHS. We observed profound exacerbation of CHS in DP−/− mice. CRTH2−/−/DP−/− mice showed similar exacerbation, but to a lesser extent. These symptoms were accompanied by increased production of interferon-γ and IL-17. The increase in IL-17 producing γδ T cells was marked and presumably contributed to the enhanced CHS. DP deficiency promoted the in vivo migration of dendritic cells to regional lymph nodes. A DP agonist added to DCs in vitro was able to inhibit production of IL-12 and IL-1β. Interestingly, production of IL-10 in dendritic cells was elevated via the DP pathway, but it was lowered by the CRTH2 pathway. Collectively, PGD2 signals through CRTH2 to mediate CHS inflammation, and conversely, DP signals to exert inhibitory effects on CHS. Thus, we report opposing functions for PGD2 that depend on receptor usage in allergic reactions. Prostaglandin D2 (PGD2) exerts its effects through two distinct receptors: the chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) and the D prostanoid (DP) receptor. Our previous study demonstrated that CRTH2 mediates contact hypersensitivity (CHS) in mice. However, the function of DP receptor remains to be fully established. In this study, we examine the pathophysiological roles of PGD2 using DP-deficient (DP−/−) and CRTH2/DP-deficient (CRTH2−/−/DP−/−) mice to elucidate receptor-mediated PGD2 action in CHS. We observed profound exacerbation of CHS in DP−/− mice. CRTH2−/−/DP−/− mice showed similar exacerbation, but to a lesser extent. These symptoms were accompanied by increased production of interferon-γ and IL-17. The increase in IL-17 producing γδ T cells was marked and presumably contributed to the enhanced CHS. DP deficiency promoted the in vivo migration of dendritic cells to regional lymph nodes. A DP agonist added to DCs in vitro was able to inhibit production of IL-12 and IL-1β. Interestingly, production of IL-10 in dendritic cells was elevated via the DP pathway, but it was lowered by the CRTH2 pathway. Collectively, PGD2 signals through CRTH2 to mediate CHS inflammation, and conversely, DP signals to exert inhibitory effects on CHS. Thus, we report opposing functions for PGD2 that depend on receptor usage in allergic reactions. Prostaglandin (PGD) D2 is an arachidonic acid metabolite that exerts a range of biological activities including vasodilatation, bronchoconstriction, and inhibition of platelet aggregation.1Beasley C.R. Robinson C. Featherstone R.L. Varley J.G. Hardy C.C. Church M.K. Holgate S.T. 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.J Clin Invest. 1987; 79: 978-983Crossref PubMed Scopus (80) Google Scholar, 2Nagoshi H. Uehara Y. Kanai F. Maeda S. Ogura T. Goto A. Toyo-oka T. Esumi H. Shimizu T. Omata M. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells.Circ Res. 1998; 82: 204-209Crossref PubMed Scopus (62) Google Scholar, 3Narumiya S. Toda N. Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.Br J Pharmacol. 1985; 85: 367-375Crossref PubMed Scopus (80) Google Scholar, 4Whittle B.J. Moncada S. Vane J.R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.Prostaglandins. 1978; 16: 373-388Crossref PubMed Scopus (287) Google Scholar Prostaglandin D2 (PGD2) is synthesized by the isomerization of prostaglandin H2 (PGH2) through the enzymatic activity of PGD synthase. Two types of PGD synthase have been identified: lipocalin-type PGD synthase and hematopoietic-type PGD synthase (H-PGDS).5Kanaoka Y. Urade Y. Hematopoietic prostaglandin D synthase.Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 163-167Abstract Full Text Full Text PDF PubMed Scopus (131) Google Scholar, 6Urade Y. Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence.Prostaglandins Other Lipid Mediat. 2002; 69 (375–38268)Google Scholar Although lipocalin-type PGD synthase is present in meningeal cells, epithelial cells of the choroid plexus, and oligodendrocytes in the brain, as well as being involved in the sleep-wake cycle,7Urade Y. Hayaishi O. Prostaglandin D2 and sleep regulation.Biochim Biophys Acta. 1999; 1436: 606-615Crossref PubMed Scopus (157) Google Scholar H-PGDS is principally expressed in hematopoietic cells, such as mast cells.8Christ-Hazelhof E. Nugteren D.H. Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme.Biochim Biophys Acta. 1979; 572: 43-51Crossref PubMed Scopus (127) Google Scholar, 9Urade Y. Fujimoto N. Ujihara M. Hayaishi O. Biochemical and immunological characterization of rat spleen prostaglandin D synthetase.J Biol Chem. 1987; 262: 3820-3825Abstract Full Text PDF PubMed Google Scholar On stimulation with antigens, mast cells rapidly secrete PGD2.10Lewis R.A. Soter N.A. Diamond P.T. Austen K.F. Oates J.A. Roberts 2nd, L.J. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.J Immunol. 1982; 129: 1627-1631PubMed Google Scholar, 11Urade Y. Ujihara M. Horiguchi Y. Igarashi M. Nagata A. Ikai K. Hayaishi O. Mast cells contain spleen-type prostaglandin D synthetase.J Biol Chem. 1990; 265: 371-375Abstract Full Text PDF PubMed Google Scholar In addition, recent studies indicate that a small population of Th2-type cells and dendritic cells (DCs) harbor H-PGDS, producing PGD2 in response to a variety of stimuli.12Satoh T. Moroi R. Aritake K. Urade Y. Kanai Y. Sumi K. Yokozeki H. Hirai H. Nagata K. Hara T. Utsuyama M. Hirokawa K. Sugamura K. Nishioka K. Nakamura M. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.J Immunol. 2006; 177: 2621-2629PubMed Google Scholar, 13Tanaka K. Ogawa K. Sugamura K. Nakamura M. Takano S. Nagata K. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets.J Immunol. 2000; 164: 2277-2280PubMed Google Scholar, 14Shimura C. Satoh T. Igawa K. Aritake K. Urade Y. Nakamura M. Yokozeki H. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin.Am J Pathol. 2010; 176: 227-237Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar Mounting evidence suggests that PGD2 is involved in allergic inflammation. For example, PGD2 production is observed in bronchoalveolar lavage fluid from asthmatic patients.15Miadonna A. Tedeschi A. Brasca C. Folco G. Sala A. Murphy R.C. Mediator release after endobronchial antigen challenge in patients with respiratory allergy.J Allergy Clin Immunol. 1990; 85: 906-913Abstract Full Text PDF PubMed Scopus (68) Google Scholar Mice that overproduce PGD2 exhibit an enhanced allergic lung response, eosinophilia, and increased Th2-type cytokine production.16Fujitani Y. Kanaoka Y. Aritake K. Uodome N. Okazaki-Hatake K. Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice.J Immunol. 2002; 168: 443-449PubMed Google Scholar We have demonstrated that PGD2 plays an essential role in IgE-mediated skin responses in mice.12Satoh T. Moroi R. Aritake K. Urade Y. Kanai Y. Sumi K. Yokozeki H. Hirai H. Nagata K. Hara T. Utsuyama M. Hirokawa K. Sugamura K. Nishioka K. Nakamura M. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.J Immunol. 2006; 177: 2621-2629PubMed Google Scholar In contrast, another study that used H-PGDS-deficient and/or -transgenic mice revealed protective roles of PGD2 against delayed-type hypersensitivity responses of the skin.17Trivedi S.G. Newson J. Rajakariar R. Jacques T.S. Hannon R. Kanaoka Y. Eguchi N. Colville-Nash P. Gilroy D.W. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity.Proc Natl Acad Sci USA. 2006; 103: 5179-5184Crossref PubMed Scopus (115) Google Scholar A possible antipruritic potential of PGD2 in the scratching behavior of mice has also been proposed.18Sugimoto M. Arai I. Futaki N. Hashimoto Y. Sakurai T. Honma Y. Nakaike S. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.Eur J Pharmacol. 2007; 564: 196-203Crossref PubMed Scopus (11) Google Scholar, 19Sugimoto M. Arai I. Futaki N. Honma Y. Sakurai T. Hashimoto Y. Nakaike S. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching.Prostaglandins Leukot Essent Fatty Acids. 2007; 76: 93-101Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar Thus, whether PGD2 facilitates or down-regulates allergic processes has yet to be determined. PGD2 exerts its effects through the D prostanoid (DP) receptor and the chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) receptor. DP and CRTH2 are members of the G protein-coupled, seven transmembrane receptor family. DP is coupled with the Gαs protein, whereas Gαi protein is associated with CRTH2.20Hirai H. Tanaka K. Yoshie O. Ogawa K. Kenmotsu K. Takamori Y. Ichimasa M. Sugamura K. Nakamura M. Takano S. Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.J Exp Med. 2001; 193: 255-261Crossref PubMed Scopus (964) Google Scholar DP-mediated signals inhibit DC migration.21Angeli V. Faveeuw C. Roye O. Fontaine J. Teissier E. Capron A. Wolowczuk I. Capron M. Trottein F. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.J Exp Med. 2001; 193: 1135-1147Crossref PubMed Scopus (231) Google Scholar, 22Angeli V. Staumont D. Charbonnier A.S. Hammad H. Gosset P. Pichavant M. Lambrecht B.N. Capron M. Dombrowicz D. Trottein F. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses.J Immunol. 2004; 172: 3822-3829PubMed Google Scholar, 23Hammad H. de Heer H.J. Soullie T. Hoogsteden H.C. Trottein F. Lambrecht B.N. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1.J Immunol. 2003; 171: 3936-3940PubMed Google Scholar In eosinophils, mobilization from bone marrow and chemotaxis are promoted by DP.24Schratl P. Royer J.F. Kostenis E. Ulven T. Sturm E.M. Waldhoer M. Hoefler G. Schuligoi R. Lippe I.T. Peskar B.A. Heinemann A. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking.J Immunol. 2007; 179: 4792-4799PubMed Google Scholar A DP agonist has also been shown to sustain the survival of eosinophils.25Gervais F.G. Cruz R.P. Chateauneuf A. Gale S. Sawyer N. Nantel F. Metters K.M. O'Neill G.P. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.J Allergy Clin Immunol. 2001; 108: 982-988Abstract Full Text Full Text PDF PubMed Scopus (226) Google Scholar On the other hand, CRTH2 is expressed in eosinophils, basophils, and a subpopulation of Th2 cells, in particular, central memory Th2 cells and monocytes.26Nagata K. Hirai H. Tanaka K. Ogawa K. Aso T. Sugamura K. Nakamura M. Takano S. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s).FEBS Lett. 1999; 459: 195-199Abstract Full Text Full Text PDF PubMed Scopus (276) Google Scholar, 27Nagata K. Tanaka K. Ogawa K. Kemmotsu K. Imai T. Yoshie O. Abe H. Tada K. Nakamura M. Sugamura K. Takano S. Selective expression of a novel surface molecule by human Th2 cells in vivo.J Immunol. 1999; 162: 1278-1286PubMed Google Scholar, 28Wang Y.H. Ito T. Homey B. Watanabe N. Martin R. Barnes C.J. McIntyre B.W. Gilliet M. Kumar R. Yao Z. Liu Y.J. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.Immunity. 2006; 24: 827-838Abstract Full Text Full Text PDF PubMed Scopus (269) Google Scholar CRTH2 signals induce calcium mobilization and chemotaxis in eosinophils and basophils.20Hirai H. Tanaka K. Yoshie O. Ogawa K. Kenmotsu K. Takamori Y. Ichimasa M. Sugamura K. Nakamura M. Takano S. Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.J Exp Med. 2001; 193: 255-261Crossref PubMed Scopus (964) Google Scholar Eosinophil degranulation is promoted by CRTH2 stimulation.25Gervais F.G. Cruz R.P. Chateauneuf A. Gale S. Sawyer N. Nantel F. Metters K.M. O'Neill G.P. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.J Allergy Clin Immunol. 2001; 108: 982-988Abstract Full Text Full Text PDF PubMed Scopus (226) Google Scholar In addition, CRTH2 signals enhance IL-4, IL-5, and IL-13 production from Th2 cells.29Tanaka K. Hirai H. Takano S. Nakamura M. Nagata K. Effects of prostaglandin D2 on helper T cell functions.Biochem Biophys Res Commun. 2004; 316: 1009-1014Crossref PubMed Scopus (106) Google Scholar CRTH2 expression is increased in eosinophils of atopic dermatitis, chronic urticaria, and in prurigo patients.30Yahara H. Satoh T. Miyagishi C. Yokozeki H. Increased expression of CRTH2 on eosinophils in allergic skin diseases.J Eur Acad Dermatol Venereol. 2010; 24: 75-76Crossref PubMed Scopus (30) Google Scholar CRTH2-expressing T cells are elevated in the blood of atopic dermatitis.31Iwasaki M. Nagata K. Takano S. Takahashi K. Ishii N. Ikezawa Z. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis.J Invest Dermatol. 2002; 119: 609-616Crossref PubMed Scopus (92) Google Scholar Despite the different lines of evidence previously mentioned, the in vivo roles of DP in inflammation are somewhat controversial. Mice with targeted disruption of the DP gene exhibit reduced eosinophil infiltration into the lung and fail to develop airway hyperreactivity.32Matsuoka T. Hirata M. Tanaka H. Takahashi Y. Murata T. Kabashima K. Sugimoto Y. Kobayashi T. Ushikubi F. Aze Y. Eguchi N. Urade Y. Yoshida N. Kimura K. Mizoguchi A. Honda Y. Nagai H. Narumiya S. Prostaglandin D2 as a mediator of allergic asthma.Science. 2000; 287: 2013-2017Crossref PubMed Scopus (672) Google Scholar Inhibition of DP alleviates asthmatic responses in guinea pigs.33Arimura A. Yasui K. Kishino J. Asanuma F. Hasegawa H. Kakudo S. Ohtani M. Arita H. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist.S-5751 J Pharmacol Exp Ther. 2001; 298: 411-419PubMed Google Scholar Conversely, a DP agonist has been shown to down-regulate murine models of atopic dermatitis22Angeli V. Staumont D. Charbonnier A.S. Hammad H. Gosset P. Pichavant M. Lambrecht B.N. Capron M. Dombrowicz D. Trottein F. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses.J Immunol. 2004; 172: 3822-3829PubMed Google Scholar and allergic asthma.34Hammad H. Kool M. Soullie T. Narumiya S. Trottein F. Hoogsteden H.C. Lambrecht B.N. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells.J Exp Med. 2007; 204: 357-367Crossref PubMed Scopus (168) Google Scholar Similarly, the roles of CRTH2 in vivo are controversial. Although studies using mice lacking the CRTH2 gene have demonstrated alleviated responses in airway hyperreactivity,35Shiraishi Y. Asano K. Niimi K. Fukunaga K. Wakaki M. Kagyo J. Takihara T. Ueda S. Nakajima T. Oguma T. Suzuki Y. Shiomi T. Sayama K. Kagawa S. Ikeda E. Hirai H. Nagata K. Nakamura M. Miyasho T. Ishizaka A. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation.J Immunol. 2008; 180: 541-549Crossref PubMed Scopus (73) Google Scholar nasal pollinosis,36Nomiya R. Okano M. Fujiwara T. Maeda M. Kimura Y. Kino K. Yokoyama M. Hirai H. Nagata K. Hara T. Nishizaki K. Nakamura M. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice.J Immunol. 2008; 180: 5680-5688Crossref PubMed Scopus (55) Google Scholar IgE-mediated skin inflammation,12Satoh T. Moroi R. Aritake K. Urade Y. Kanai Y. Sumi K. Yokozeki H. Hirai H. Nagata K. Hara T. Utsuyama M. Hirokawa K. Sugamura K. Nishioka K. Nakamura M. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.J Immunol. 2006; 177: 2621-2629PubMed Google Scholar and cedar pollen dermatitis,37Oiwa M. Satoh T. Watanabe M. Niwa H. Hirai H. Nakamura M. Yokozeki H. CRTH2-dependent STAT6-independent induction of cedar pollen dermatitis.Clin Exp Allergy. 2008; 38: 1357-1366Crossref PubMed Scopus (42) Google Scholar other groups have shown enhanced eosinophil recruitment into the lung in an asthmatic model of CRTH2-deficient mice.38Chevalier E. Stock J. Fisher T. Dupont M. Fric M. Fargeau H. Leport M. Soler S. Fabien S. Pruniaux M.P. Fink M. Bertrand C.P. McNeish J. Li B. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment.J Immunol. 2005; 175: 2056-2060PubMed Google Scholar The reasons for such discrepancies in the different animal models of allergic diseases cannot be fully explained, suggesting that the function of PGD2 in inflammation may be more complex than previously thought. Thus, to develop new therapeutic strategies, it is crucial to delineate the physiological roles of PGD2 in each step of the inflammatory pathway with respect to the involvement of individual receptors. Contact hypersensitivity (CHS), a well-characterized model of allergic skin inflammation, is an immune response to a reactive hapten covalently coupled to a cell surface protein. DCs in the skin capture and process antigens. They migrate to regional lymph node (LN) cells and present antigens to T cells. Antigen-specific T cells are recruited to the skin in response to subsequent exposure to haptens. They mediate allergic responses through the release of a variety of cytokine and chemokine production from resident cells. This leads to the accumulation of effector cells, such as neutrophils and eosinophils. It has been revealed that Th1- and Th17-type immunity contributes to the development of CHS.39Abe M. Kondo T. Xu H. Fairchild R.L. Interferon-gamma inducible protein (IP-10) expression is mediated by CD8+ T cells and is regulated by CD4+ T cells during the elicitation of contact hypersensitivity.J Invest Dermatol. 1996; 107: 360-366Crossref PubMed Scopus (56) Google Scholar, 40Akiba H. Kehren J. Ducluzeau M.T. Krasteva M. Horand F. Kaiserlian D. Kaneko F. Nicolas J.F. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.J Immunol. 2002; 168: 3079-3087PubMed Google Scholar, 41Gautam S. Battisto J. Major J.A. Armstrong D. Stoler M. Hamilton T.A. Chemokine expression in trinitrochlorobenzene-mediated contact hypersensitivity.J Leukoc Biol. 1994; 55: 452-460PubMed Google Scholar, 42He D. Wu L. Kim H.K. Li H. Elmets C.A. Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.J Immunol. 2006; 177: 6852-6858PubMed Google Scholar, 43He D. Wu L. Kim H.K. Li H. Elmets C.A. Xu H. IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.J Immunol. 2009; 183: 1463-1470Crossref PubMed Scopus (92) Google Scholar, 44Kish D.D. Li X. Fairchild R.L. CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge.J Immunol. 2009; 182: 5949-5959Crossref PubMed Scopus (68) Google Scholar, 45Nakae S. Komiyama Y. Nambu A. Sudo K. Iwase M. Homma I. Sekikawa K. Asano M. Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.Immunity. 2002; 17: 375-387Abstract Full Text Full Text PDF PubMed Scopus (911) Google Scholar, 46Tokuriki A. Seo N. Ito T. Kumakiri M. Takigawa M. Tokura Y. Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression.J Dermatol Sci. 2002; 28: 234-241Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar, 47Wang B. Fujisawa H. Zhuang L. Freed I. Howell B.G. Shahid S. Shivji G.M. Mak T.W. Sauder D.N. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.J Immunol. 2000; 165: 6783-6790PubMed Google Scholar, 48Xu H. Banerjee A. Dilulio N.A. Fairchild R.L. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.J Immunol. 1997; 158: 4721-4728PubMed Google Scholar, 49Xu H. DiIulio N.A. Fairchild R.L. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.J Exp Med. 1996; 183: 1001-1012Crossref PubMed Scopus (373) Google Scholar In particular, CD8(+) cells producing interferon (IFN)-γ and/or IL-17 play essential roles in the elicitation phase of CHS,42He D. Wu L. Kim H.K. Li H. Elmets C.A. Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.J Immunol. 2006; 177: 6852-6858PubMed Google Scholar, 43He D. Wu L. Kim H.K. Li H. Elmets C.A. Xu H. IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.J Immunol. 2009; 183: 1463-1470Crossref PubMed Scopus (92) Google Scholar, 44Kish D.D. Li X. Fairchild R.L. CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge.J Immunol. 2009; 182: 5949-5959Crossref PubMed Scopus (68) Google Scholar although Th2-type immune responses also seem to be involved.50Asherson G.L. Dieli F. Sireci G. Salerno A. Role of IL-4 in delayed type hypersensitivity.Clin Exp Immunol. 1996; 103: 1-4Crossref PubMed Scopus (40) Google Scholar, 51Dieli F. Asherson G.L. Romano G.C. Sireci G. Gervasi F. Salerno A. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines Role of gamma/delta cells.J Immunol. 1994; 152: 2698-2704PubMed Google Scholar, 52Salerno A. Dieli F. Sireci G. Bellavia A. Asherson G.L. Interleukin-4 is a critical cytokine in contact sensitivity.Immunology. 1995; 84: 404-409PubMed Google Scholar In the present study, we examined the respective roles of PGD2 receptors in CHS using genetically modified mice. Our results demonstrate that PGD2 exerts both allergic and anti-allergic roles in inflammation, which are mediated through the reciprocal functions of CRTH2 and DP, respectively. This suggests protective roles for PGD2 under normal physiological and pathogenic conditions. BALB/c mice were purchased from Sankyo Labo Service (Tokyo, Japan). CRTH2−/− mice, DP−/− mice, and H-PGDS−/− mice have been previously described.12Satoh T. Moroi R. Aritake K. Urade Y. Kanai Y. Sumi K. Yokozeki H. Hirai H. Nagata K. Hara T. Utsuyama M. Hirokawa K. Sugamura K. Nishioka K. Nakamura M. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.J Immunol. 2006; 177: 2621-2629PubMed Google Scholar, 17Trivedi S.G. Newson J. Rajakariar R. Jacques T.S. Hannon R. Kanaoka Y. Eguchi N. Colville-Nash P. Gilroy D.W. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity.Proc Natl Acad Sci USA. 2006; 103: 5179-5184Crossref PubMed Scopus (115) Google Scholar, 32Matsuoka T. Hirata M. Tanaka H. Takahashi Y. Murata T. Kabashima K. Sugimoto Y. Kobayashi T. Ushikubi F. Aze Y. Eguchi N. Urade Y. Yoshida N. Kimura K. Mizoguchi A. Honda Y. Nagai H. Narumiya S. Prostaglandin D2 as a mediator of allergic asthma.Science. 2000; 287: 2013-2017Crossref PubMed Scopus (672) Google Scholar Receptor null (CRTH2−/−/DP−/−) mice were generated in Tokyo Medical and Dental University by crossing each of the receptor-deficient mice. Mice lacking PGD2 receptors and those that lack H-PGDS genes are on a BALB/c background. Mice were maintained under specific pathogen-free conditions in our animal facility. The use of animals was in full compliance with the Committee for Animal Experiments of Tokyo Medical and Dental University. Fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD4 (CD4-FITC, GK1.5), CD8 (CD8-FITC, 53–6.7), and γδ T cell receptor (TCR) (γδ TCR-FITC, UC7-13D5) antibodies (Abs), phycoerythrin (PE)-conjugated anti-mouse IL-13 (IL-13-PE, eBio 13A), and CD25 (CD25-PE, PC61.5) Abs, biotin-conjugated anti-mouse γδ TCR (γδ TCR-Biotin, GL-3) Ab, PE-Cy5-conjugated anti-mouse Foxp (Foxp3-PE-Cy5, FJK-16s) Ab, and anti-mouse CD28 (clone 37.51) Ab were purchased from eBioscience (San Diego, CA). FITC-conjugated anti-mouse I-Ad (I-Ad –FITC, AMS-32.1) and CD86 (CD86-FITC, GL1) Abs, and PE conjugated anti-mouse CD11c (CD11c-PE, HL3), IFN-γ (IFN-γ-PE, XMG 1.2), and CD16/CD32 (2.4G2) Abs were from BD Biosciences Pharmingen (Franklin Lakes, NJ). PE-conjugated IL-17 (IL-17-PE, TC11-18H10.1), anti-IL-17 (TC11-18H10.1), and IFN-γ (XMG 1.2) Abs were from BioLegend (San Diego, CA) , and anti-IL-13 (eBio 1316H) Ab was from R&D Systems (Minneapolis, MN). Acute CHS was induced by applying 100 μL of 5% 2,4,6-trinitrochlorobenzene (TNCB) (Nacalai Tesque, Kyoto, Japan) in ethanol:acetone (3:1), or 100 μL of 0.5% 2,4-dinitrofluorobenzene (Nacalai Tesque) in acetone:olive oil (4:1). On day 5, each ear lobe was challenged with 20 μL of 1% TNCB in acetone:olive oil (1:4) or 0.2% 2,4-dinitrofluorobenzene in acetone:olive oil (4:1). Ear thickness was determined before and after each challenge. Control ears were challenged with the respective vehicles. Irritation dermatitis was induced by painting 20 μL of 1% croton oil (Nacalai Tesque) in acetone on mouse ear lobes. Ear thickness was measured with a dial thickness gauge (Peacock, Tokyo, Japan) immediately before and after painting and expressed as the mean increment in thickness above basal line control value. Single cell suspensions were prepared in PBS containing 5% fetal calf serum and 0.1% NaN3. After blocking IgG receptors with anti-mouse CD16/CD32 monoclonal Ab, cells were stained with the first Abs against cell surface markers. Intracellular staining was performed by IntraStain kit (Dako Cytomation, Glostrup, Denmark). Spleen cells (SCs) obtained from naive mice were adjusted to 5 × 107 cells/mL and mixed with equal volumes of 10 mmol/L TNBS (2,4,6-trinitrobenzene sulfonic sodium salt) (Nacalai Tesque) in PBS. Cells were then incubated at 37°C for 30 minutes, washed three times and incubated with mytomycin C (Kyowa Hakko Kirin, Tokyo, Japan) at 50 μg/mL, at 37°C for 40 minutes, followed by three further washes with PBS. Axillary and abdominal LNs were collected on day 5 from mice sensitized with TNCB (day 0). Single cell suspensions were prepared by teasing the LN. Immune LN cells (400 μL of 5 × 106 cells/mL) were incubated with 400 μL of 5 × 106 trinitrophenyl (TNP)-SC/mL in a 24-well plate for 24 hours and supernatants were collected and stored at −80°C until use. For the detection of intracellular cytokines, immune LN cells incubated with trinitrophenyl-spleen cells (TNP-SC) for 48 hours were stimulated with 50 ng/mL (phorbol 12-myristate 13-acetate, Sigma Aldrich, St. Louis, MO), 500 ng/mL ionomycin (Calbiochem, San Diego, CA) , and 5 μg/mL Brefeldin A (Sigma Aldrich) for a further 12 hours. They were then analyzed with a flow cytometer. Naive CD4 T cells were isolated using CD4(+)/CD62L (+) T cell isolation Kit II (Miltenyi Biotec, Bergisch Gladbach, Germany). The cells were stimulated in CD3-coated plates (BD Biosciences Pharmingen) with anti-mouse CD28 Ab (1 μg/mL), and cultured for 4 days in the presence of IL-12 (5 ng/mL), IL-2 (10 ng/mL), and anti-mouse IL-4 Ab (10 μg/mL) for Th 1 cells, IL-4 (5 ng/mL), IL-2 (10 ng/mL), and anti-mouse IFN-γ Ab (10 μg/mL) for Th2 cells, and IL-6 (20 ng/mL), transforming growth factor-β (10 ng/mL), anti-mouse IL-4 Ab (10 μg/mL), and anti-mouse IFN-γ Ab (10 μg/mL) for Th17 cells. γδ T cells were prepared using the TCR γδ (+) T cell isolation kit (Miltenyi Biotec). The γδ T cells were more than 95% pure. Immune LN cells were transferred into each ear lobe (1 × 106 cells/30 μL/ear) into naive mice that immediately received challenge. Inguinal and axillary LN cells were collected from mice sacrificed at 24 hours after application of 1% FITC (Sigma Aldrich) in acetone:dibutyl phthalate (1:1) onto the abdominal skin. Cells were incubated with CD11

Referência(s)